You are subscribed to CVM What's New, for newly posted information on the U.S. Food & Drug Administration's (FDA) Center for Veterinary Medicine's (CVM) Website.
This information has recently been updated and is now available.
Letter to Veterinarians re: INCURIN (estriol) Tablets and PROIN (phenylpropanolamine hydrochloride) Chewable Tablets – http://www.fda.gov/AnimalVeterinary/SafetyHealth/ProductSafetyInformation/ucm277198.htm
Letter to Pharmacy Professionals re: INCURIN (estriol) Tablets and PROIN (phenylpropanolamine hydrochloride) Chewable Tablets – http://www.fda.gov/AnimalVeterinary/SafetyHealth/ProductSafetyInformation/ucm277199.htm
Letter to Veterinarians re: PRASCEND (pergolide mesylate) Tablets – http://www.fda.gov/AnimalVeterinary/SafetyHealth/ProductSafetyInformation/ucm277207.htm
Letter to Pharmacy Professionals re: PRASCEND (pergolide mesylate) Tablets – http://www.fda.gov/AnimalVeterinary/SafetyHealth/ProductSafetyInformation/ucm277208.htm
Visit our home page at http://www.fda.gov/AnimalVeterinary/default.htm
| This email was sent to list-fda@xxxxxxxxxxx using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 |  |
